The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein

Journal of Cellular Physiology

Volumn 196, Issue 2, 2003, Pages 251-257

  Loregian, Arianna ^a   Bortolozzo, Katia ^a   Boso, Silvia ^a   Sapino, Barbara ^a   Betti, Monica ^b   Biasolo, Maria A ^a   Caputo, Antonella ^b   Palú, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SOLID PHASE EXTRACTION; WESTERN BLOTTING;

ADSORPTION; BLOTTING, WESTERN; CELL NUCLEUS; GENE PRODUCTS, TAT; HIV-1; SACCHAROMYCES CEREVISIAE; SP1 TRANSCRIPTION FACTOR; TWO-HYBRID SYSTEM TECHNIQUES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038121802     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10271     Document Type: Article

References (37)

1. Bogerd HP, Fridell RA, Blair WS, Cullen BR. 1993. Genetic evidence that Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus. J Virol 67:5030-5034.
2. Breeden L, Nasmyth K. 1985. Regulation of the yeast HO gene. Cold Spring Harb Symp Quant Biol 50:643-650.
3. Breeden L, Nasmyth K. 1987. Cell cycle control of the yeast HO gene: cis and trans-acting regulators. Cell 48:389-397.
4. Chiang CM, Roeder RG. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267:531-536.
5. Chun R, Semmes OJ, Neuvet C, Jeang KT. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J Virol 72:2615-2629.
6. Corallini A, Campioni D, Rusnati M, Betti M, Ciomei M, Sola F, Calza N, Zauli G, Presta M, Barbanti-Brodano G, Caputo A. 1998. Characterization of the effects of two distamycin A derivatives, PNU145156E and PNU153429, on HIV-1 Tat protein. AIDS Res Hum Retrov 14:1561-1571.
7. Emili A, Greenblatt J, Ingles CJ. 1994. Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol 14:1582-1593.
8. Fridell RA, Harding LS, Bogerd HP, Cullen BR. 1995. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209:347-357.
9. Gallia GL, Johnson EM, Khalili K. 2000. Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res 28:3197-3205.
10. Greene WC. 1990. Regulation of HIV-1 gene expression. Annu Rev Immunol 8:453-475.
11. Haidweger E, Novy M, Rotheneder H. 2001. Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol 306:201-212.
12. Hardy CFJ, Sussel L, Shore D. 1992. A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. Genes Dev 6:801-814.
13. Huang L-M, Jeang KT. 1993. Increased spacing between SP1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. J Virol 67:6937-6944.
14. Jeang KT, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol 67:6224-6233.
15. Kamine J, Chinnadurai G. 1992. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol 66:3932-3936.
16. Kamine J, Subramanian T, Chinnadurai G. 1991. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 88:8510-8514.
17. Kamine J, Subramanian T, Chinnadurai G. 1993. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation of acidic transcriptional activators. J Virol 67:6828-6834.
18. Kamine J, Elangovan B, Subramanian T, Coleman D, Chinnadurai G. 1996. Identification of a cellular protein that specifically interacts with the essential cysteine region of HIV-1 Tat transactivator. Virology 216:357-366.
19. Kashanchi F, Piras G, Radonovich MF, Duvall JF, Fattacy A, Chiang CM, Roeder RG, Brady JN. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367:295-299.
20. Kunzler M, Braus GH, Georgiev O, Seipel K, Schaffner W. 1994. Functional differences between mammalian transcription activation domains at the yeast GAL1 promoter. EMBO J 13:641-645.
21. Loregian A, Papini E, Satin B, Marsden HS, Hirst TR, Palù G. 1999. Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci USA 96:5221-5226.
22. Loregian A, Marsden HS, Palù G. 2002. Protein-protein interactions as targets for antiviral chemotherapy. Rev Med Virol 12:239-262.
23. Madore SJ, Cullen BR. 1995. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Virology 106:1150-1154.
24. Moretti P, Freeman K, Coodly L, Shore D. 1994. Evidence that a complex of SIR proteins interacts with the silencers and telomere-binding protein RAP1. Genes Dev 8:2257-2269.
25. Nelbock P, Dillon PJ, Perkins A, Rosen CA. 1990. A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248:1650-1653.
26. Pagtakhan AS, Tong-Starksen SE. 1997. Interactions between Tat of HIV-2 and transcription factor Sp1. Virology 238:221-230.
27. Pascal E, Tijan R. 1991. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5:1646-1656.
28. Pugh BF, Tjian R. 1990. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 61:1187-1197.
29. Rose MD, Winston R, Hieter P. 1990. In: Methods in yeast genetics: A laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
30. Salfeld J, Gottlinger HG, Sia RA, Park RE, Sodroski JG, Haseltine WA. 1990. A tripartite HIV-1 tat-env-rev fusion protein. EMBO J 9:965-970.
31. Schiestl RH, Giest RD. 1989. High efficiency transformation of intact yeast cells using single stranded nucleic acid as a carrier. Curr Genet 16:339-346.
32. Southgate CD, Green MR. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev 5:2496-2507.
33. Stephens DJ, Banting G. 2000. The use of yeast two-hybrid screens in studies of protein: protein interactions. Traffic 1:763-768.
34. Subramanian T, D'Sa-Eipper C, Elangovan B, Chinnadurai G. 1994. The activation of Tat protein of immunodeficiency virus type-1 functions in yeast. Nucleic Acids Res 22:1496-1499.
35. Sune C, Garcia-Blanco MA. 1995. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J Virol 69:6572-6576.
36. Suske G. 1999. The Sp-family of transcription factors Gene 238:291-300.
37. Wei P, Garber ME, Fang S, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.